Pipeline progress Towards the end of 2017 we received approvals for three key new products: Shingrix, our new vaccine which represents a new standard for the prevention of shingles; Juluca, the first in a series
SHINGRIX is an FDA-approved vaccine for the prevention of shingles (herpes zoster): in adults 50 years and older. in adults 18 years and older who are or will be at increased risk of shingles due to being immunocompromised by known disease or therapy. SHINGRIX is not used to prevent chicke...
“Shingrix is a great vaccine. It’s really, really effective. And shingles is a pretty morbid illness for older adults, so it’s great that it exists. But with an … adjuvant,”— a compound that amplifies the impact of the vaccine —“you’re not going to give it at the same visi...
根据第一部分SHINGRIX is an FDA-approved vaccine(疫苗)for the prevention of shingles(带状疱疹)in adults 50 years and older.SHINGRIX是FDA批准的疫苗,为50岁及以上的成年人准备的预防带状疱疹的疫苗。可知,该疫苗是为50岁以上的老人准备的,故选B。(2)C.推理判断题。根据Additional important...
the strategy is more advanced than is visible externally.’” Shingrix was cited by Walmsley as one of the company’s growth drivers. And earlier this week, the company cut a deal with pharmacy chain CVS to have the shingles vaccine available for patients. CVS has almost 10,000 pharmacies ...
Pipeline progress Towards the end of 2017 we received approvals for three key new products: Shingrix, our new vaccine which represents a new standard for the prevention of shingles; Juluca, the first in a series of 2-drug regimens for HIV which reduces the number of drugs patients take as ...